Related Experiment Video
Updated: Aug 12, 2026
06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy
1Northeastern University, Bouve College of Health Sciences School of Pharmacy, Department of Pharmaceutical Sciences, Boston, MA 02115, USA. vweissig@hotmail.com
Current Pharmaceutical Biotechnology
|July 27, 2001
Summary
Mitochondrial DNA (mtDNA) defects lack effective treatments. Researchers developed DQAsomes, a novel mitochondria-specific vector, for targeted DNA delivery to mitochondria, offering a potential gene therapy approach.
Area of Science:
- Mitochondrial biology
- Gene therapy
- Nanomedicine
Background:
- Mitochondrial DNA (mtDNA) defects are linked to numerous diseases, with limited treatment options due to the central role of oxidative metabolism.
- Conventional therapies are ineffective for mtDNA defects because the metabolic pathway cannot be bypassed.
- Existing gene therapy approaches for mitochondria are theoretical, requiring specific delivery vectors.
Purpose of the Study:
- To develop a novel, mitochondria-specific vector for DNA delivery.
- To overcome the limitations of current treatments for mitochondrial DNA defects.
- To explore gene therapeutic strategies for mitochondrial diseases.
Main Methods:
- Analysis of dequalinium's self-assembly properties for DNA delivery.
- Development and preparation of dequalinium-based vesicles, termed DQAsomes.
- Testing DQAsome-DNA complex binding, protection, and selective release using cardiolipin-rich liposomes.
Main Results:
- DQAsomes were successfully prepared from dequalinium, a mitochondria-accumulating compound.
- DQAsomes demonstrated efficient DNA binding and protection.
- Selective DNA release was observed at liposomes mimicking mitochondrial membranes, indicating targeted delivery potential.
Conclusions:
- DQAsomes represent a novel strategy for mitochondria-specific DNA delivery.
- These DQAsomes show promise as the first vector capable of delivering DNA to mitochondria in living cells.
- This breakthrough could pave the way for effective gene therapies for mitochondrial diseases.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.